• Users Online: 241
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2020  |  Volume : 5  |  Issue : 2  |  Page : 53-56

Oxcarbazepine as a safe therapy for the management of trigeminal neuralgia (Trileptal®): Case series and review article


Department of Diagnostic Sciences and Oral Biology, College of Dentistry, King Khalid University, Abha, Kingdom of Saudi Arabia

Correspondence Address:
Dr. Khalil Ibrahim Assiri
Department of Diagnostic Sciences and Oral Biology, College of Dentistry, King Khalid University, Abha
Kingdom of Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/KKUJHS.KKUJHS_11_20

Rights and Permissions

Oxcarbazepine is an effective antiepileptic medication. It is typically used alone or in conjunction with other drugs to treat partial seizures and is believed to be the first line for the treatment of trigeminal neuralgia, which is a sharp pain attack lasting for seconds in orofacial territories and the distribution of the trigeminal nerve and its branches. Its therapeutic effectiveness is comparable to carbamazepine, but it has better pharmacokinetic properties, is better tolerated, and has a safe profile compared to carbamazepine drug-to-drug interactions and general side effects.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed322    
    Printed6    
    Emailed0    
    PDF Downloaded44    
    Comments [Add]    

Recommend this journal